Cost-effectiveness of liver cancer screening
Authors:
- Alessandro CucchettiACAlessandro Cucchetti
- Matteo CesconMCMatteo Cescon
- Virginia ErroiVEVirginia Erroi
- Antonio D. PinnaAPAntonio D. Pinna
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 27 (6) , 961-972
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicitiesHepatology, 2010
- Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?Hepatology, 2010
- Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospitalJournal of Gastroenterology and Hepatology, 2010
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysisBritish Journal of Cancer, 2008
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Hepatocellular carcinoma in primary biliary cirrhosisJournal of Hepatology, 1994